Showing results (151-160 of 204) with videos related to
Sort By:
Pageof 21
Disease Models & Mechanisms|November 16, 2014
Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in ratsVíctor Fernández-Dueñas, Jaume J Taura, Martin Cottet, et al.Annals of the New York Academy of Sciences|November 21, 2009
Insider access: pepducin symposium explores a new approach to GPCR modulationJacquelyn Miller, Anika Agarwal, Lakshmi A Devi, et al.Molecular Pharmacology|May 17, 2019
Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3Joyce Heuninck, Cristina Perpiñá Viciano, Ali Işbilir, et al.Nature Communications|February 27, 2026
Allosteric activation of the glutamate receptor mGlu2 by the serotonin receptor 5-HT2ASiyu Gai, Li Lin, Jiyong Meng, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 29, 2013
Alleviating pain hypersensitivity through activation of type 4 metabotropic glutamate receptorBruno Vilar, Jérôme Busserolles, Bing Ling, et al.Iscience|July 5, 2024
Photoswitchable positive allosteric modulators of metabotropic glutamate receptor 4 to improve selectivitySilvia Panarello, Aleix González-Díez, Alice E Berizzi, et al.Journal of Medicinal Chemistry|December 9, 2017
From the Promiscuous Asenapine to Potent Fluorescent Ligands Acting at a Series of Aminergic G-Protein-Coupled ReceptorsCandide Hounsou, Corinne Baehr, Vincent Gasparik, et al.Iscience|November 15, 2021
GABAB1e promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12Bo Wei, Yini Zhu, Peng Yang, et al.ACS Chemical Biology|October 29, 2014
Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1/D3 heterodimerCandide Hounsou, Jean-François Margathe, Nadia Oueslati, et al.Methods in Molecular Biology (Clifton, N.J.)|December 20, 2018
HTRF® Total and Phospho-YAP (Ser127) Cellular AssaysDiana Zindel, Claire Vol, Odile Lecha, et al.Pageof 21